T1211 Safety and Tolerability of Twice-Daily Balsalazide Tablets: Results from 2 Randomized, Double-Blind, Multicenter, Phase 3 Studies and 1 Open-Label, Multicenter, Phase 3 Study

Autor:	Roland D. Shepard, Audrey L. Shaw, Lawrence Wruble, Alana A. Rosen, Shahriar Sedghi, William P. Forbes, Shirley Huang, Ron E. Pruitt, Shadreck M. Mareya
Rok vydání:	2009
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology Urology Phases of clinical research Balsalazide Double blind chemistry.chemical_compound chemistry Tolerability Phase (matter) Medicine Open label business
Zdroj:	Gastroenterology. 136:A-523
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(09)62406-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ea8b0d8683fd62afa7625701757cad09 https://doi.org/10.1016/s0016-5085(09)62406-9 Zobrazit plný text záznamu